Table 4 Change from Baseline by Patient Global Assessment
| Â | Not Improved Mean (SD) | Improved Mean (SD) | Difference | p-value | 95% C.I. |
|---|---|---|---|---|---|
4 Months | Â | Â | Â | Â | Â |
West | 0.55 (1.23) | 0.50 (0.77) | 0.05 | 0.904 | -0.55 to 0.65 |
2-PD* | - 0.10 (1.31) | - 0.77 (1.07) | 0.67 | 0.158 | -0.11 to 1.44 |
Locognosia | 1.30 (7.17) | 2.09 (4.95) | - 0.79 | 0.747 | -4.55 to 2.98 |
STI Test | 0.20 (2.15) | 1.09 (1.18) | - 0.89 | 0.235 | -1.85 to 0.08 |
Grip | -17.33 (21.2) | 12.96 (56.2) | - 30.30 | 0.007 | -66.70 to -6.11 |
Pinch | -5.30 (13.4) | 3.56 (14.3) | - 8.86 | 0.082 | -18.74 to 1.01 |
RIHM Ab | -2.36 (10.9) | -2.79 (11.0) | 0.44 | 0.924 | -8.51 to 9.38 |
RIHM Opp | 1.12 (19.2) | 0.75 (16.4) | 0.37 | 0.958 | -11.94 to 12.68 |
BCTQ Symp* | - 0.51 (0.80) | - 1.25 (0.85) | 0.74 | 0.021 | 0.15 to 1.32 |
BCTQ func* | 0.08 (0.69) | - 0.69 (0.65) | 0.77 | 0.007 | 0.31 to 1.22 |
8 Months | Â | Â | Â | Â | Â |
West | 1.07 (1.06) | 0.63 (0.76) | 0.45 | 0.318 | -0.20 to 1.10 |
2-PD* | -0.50 (2.77) | -1.06 (1.81) | 0.56 | 0.619 | -1.01 to 2.14 |
Locognosia | -0.33 (8.62) | 3.17 (6.41) | -3.50 | 0.375 | -0.49 to 3.63 |
STI Test | 1.57 (2.23) | 1.04 (1.49) | 0.53 | 0.562 | -0.76 to 1.82 |
Grip | 24.14 (84.2) | 6.90 (58.0) | 17.24 | 0.617 | -32.85 to 67.33 |
Pinch | 2.09 (19.9) | 1.93 (15.6) | 0.16 | 0.984 | -12.96 to 13.29 |
RIHM Ab | -5.55 (3.88) | -4.26 (8.66) | -1.29 | 0.565 | -9.22 to 6.64 |
RIHM Opp | 2.16 (23.7) | -0.31 (12.8) | 2.47 | 0.811 | -9.98 to 14.92 |
BCTQ Symp* | -1.14 (1.43) | -1.18 (0.85) | 0.04 | 0.944 | -0.71 to 0.79 |
BCTQ func* | -0.08 (0.87) | -0.61 (0.68) | 0.52 | 0.170 | -0.04 to 1.09 |